Biontech announces that it will supply 75 million more doses to EU

Biontech announces that it will supply 75 million more doses to EU

The German company Biontech announced on Monday that it will supply the EU with 75 million doses of its vaccine in the second quarter after optimizing its production processes.

“We continue working to increase supplies from February 15 to reach the number of doses set in the contracts,” said the company’s chief financial officer, Sierk Poetting, in a statement.
“In addition, in the second quarter we will be able to supply 75 million more doses to the EU,” he added.
That supply is part of the second EU order for 200 million doses, expected later.
Biontech’s announcement comes almost immediately before a vaccination summit called by the German government, with representatives from pharmaceutical companies and the EU.
The EU had been criticized for ordering vaccines too late and in insufficient quantities from various companies.
In addition, the producers of the three already licensed vaccines – Biontech / Pfizer, Moderna and AstraZeneca – have had production problems that have delayed their supplies to the EU, which has also generated debate.
Biontech will now be able to increase its production, according to Poetting, because optimization work has been completed at the Belgian Purus factory.
“Now, with that, we can go back to the original vaccine supply plan to the EU,” Poetting said.
In addition, the new factory in Marburg (central Germany) has received the license with which it will be able to start producing in February.
A third component is that Biontech has increased its network of cooperations in Europe.
Biontech even plans to almost double its production of vaccines in the face of world demand and to produce 2 billion doses this year compared to the 1.3 billion initially contemplated.
Ben Oakley
Ben Oakley is the guy you can really trust when it comes to Mainstream News. Whether it is something happening at the Wall Street of New York City or inside the White House in Washington, D.C., no one can cover mainstream news like Ben. Get a daily dose of Trustworthy News by Ben Oakley, only at Globe Live Media.